Regeneron’s Post

View organization page for Regeneron, graphic

478,504 followers

We are again a Best Place to Work for Disability Inclusion! We received a top score of 100 on the annual Disability Equality Index published by the American Association of People with Disabilities and Disability:IN. This honor — grounded in the passionate work of our ASPIRE Disability Inclusion ERG — reflects our ongoing efforts to foster an inclusive culture where all our colleagues can thrive. Learn more about this important recognition: https://bit.ly/3Wma4qz

  • No alternative text description for this image
Bob McCowan

SVP & CIO at Regeneron Pharmaceuticals | Digital Transformation and Innovation leader | NACD | Board Member | Technology Advisor

1mo

A shout out to our Aspire ERG team and all the supporters who continue to help educate and raise awareness across Regeneron. Your efforts are a call to action to ensure we all stay focused on this important topic. Thank you.

Congratulations on achieving this honor once again! Your commitment to disability inclusion is truly commendable. #DisabilityInclusion

Like
Reply

Congratulations on your top score!

Kelley Stineman

Project Controls Engineer at Zoetis Animal Health

1mo

As a mother with a daughter with disability who has struggled to find opportunities…I couldn’t love this more! Congratulations!!

Like
Reply
Michelle Gauthier

IT Staffing Growth Partner | Building Client Relationships & Tech Talent Solutions

1mo

Congratulations to Regeneron on this incredible achievement! 🎉 A 100 on the Disability Equality Index is a testament to your dedication to creating an inclusive workplace where everyone can thrive. The work of your ASPIRE Disability Inclusion ERG is clearly making a significant impact.

Like
Reply
Theresa Ryan Watterson

Regulatory Affairs with a focus on the EU AI Act | Medical Writer with Expertise in Medical Publications and Compliance.

4w

Great to hear!

Like
Reply
Dylan Walker

Attorney at Walker Law Firm

1mo

Well done!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics